Company intelligence / Profile preview

Parc de Salut Mar

Barcelona, Catalonia, Spain

Ownership: Private
Employees: ~2036
Development stage: Other

Overview

Hospital del Mar Research Institute is actively involved in biomedical research and recently published results in neuroscience and oncology; clinical studies on MET inhibition in SCLC are progressing toward patient trials, and population screening for COPD biomarkers is being validated.

Therapeutic areas: PsychiatryRare DiseasesPulmonologyOncologyNeurology
Modalities: Small moleculeBiologicImmunotherapyNon-pharmacological therapyDevice
Industry: Academic Hospital/University/Research

Partnerships

Affiliated with major Barcelona academic institutions (universities)Collaborates with European biomedical research networks (e.g., ENCePP)

Beyond the preview

Go deeper on Parc de Salut Mar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parc de Salut Mar.

Explore the full profile